Drug-Eluting Stents Market Report

Europe Drug-Eluting Stents Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 10, 2020
  • PAGES：208
  • REPORT CODE：GMM502306
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Drug-Eluting Stents market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Drug-Eluting Stents Market Segmentations:

    By Player:

    • Beijing AMSINO

    • Biosensors International

    • Terumo

    • Cook Medical

    • Medtronic, Inc

    • Biotronik

    • Shandong JW Medical

    • Abbott

    • Liaoning Biomedical Materials R&D Center Co, Ltd (LBC)

    • Balton

    • Boston Scientific.

    • AlviMedica Medical Technologies

    • Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

    • Lepu Medical

    • MicroPort Scientific Corporation

    By Type:

    • Rapamycin

    • Paclitaxel

    • Everolimus

    • Others

    By End-User:

    • Angina Pectoris

    • Myocardial Infarction

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Drug-Eluting Stents Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Drug-Eluting Stents Market Size and Growth Rate of Rapamycin from 2014 to 2026

    • 1.3.2 Europe Drug-Eluting Stents Market Size and Growth Rate of Paclitaxel from 2014 to 2026

    • 1.3.3 Europe Drug-Eluting Stents Market Size and Growth Rate of Everolimus from 2014 to 2026

    • 1.3.4 Europe Drug-Eluting Stents Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Drug-Eluting Stents Market Size and Growth Rate of Angina Pectoris from 2014 to 2026

    • 1.4.2 Europe Drug-Eluting Stents Market Size and Growth Rate of Myocardial Infarction from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Drug-Eluting Stents Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Drug-Eluting Stents by Major Types

      • 3.4.1 Market Size and Growth Rate of Rapamycin

      • 3.4.2 Market Size and Growth Rate of Paclitaxel

      • 3.4.3 Market Size and Growth Rate of Everolimus

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Drug-Eluting Stents Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Drug-Eluting Stents by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Drug-Eluting Stents for Angina Pectoris

      • 4.4.2 Market Size and Growth Rate of Drug-Eluting Stents for Myocardial Infarction

    5 Market Analysis by Major Regions

    • 5.1 Europe Drug-Eluting Stents Production Analysis by Top Regions

    • 5.2 Europe Drug-Eluting Stents Consumption Analysis by Top Regions

    • 5.3 Europe Drug-Eluting Stents Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.3 France Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    6 Product Circulation of Drug-Eluting Stents Market among Top Countries

    • 6.1 Top 5 Export Countries in Drug-Eluting Stents Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Drug-Eluting Stents Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Drug-Eluting Stents Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Drug-Eluting Stents Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Drug-Eluting Stents Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Drug-Eluting Stents Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Drug-Eluting Stents Landscape Analysis

    • 7.1 Germany Drug-Eluting Stents Landscape Analysis by Major Types

    • 7.2 Germany Drug-Eluting Stents Landscape Analysis by Major End-Users

    8. UK Drug-Eluting Stents Landscape Analysis

    • 8.1 UK Drug-Eluting Stents Landscape Analysis by Major Types

    • 8.2 UK Drug-Eluting Stents Landscape Analysis by Major End-Users

    9. France Drug-Eluting Stents Landscape Analysis

    • 9.1 France Drug-Eluting Stents Landscape Analysis by Major Types

    • 9.2 France Drug-Eluting Stents Landscape Analysis by Major End-Users

    10. Italy Drug-Eluting Stents Landscape Analysis

    • 10.1 Italy Drug-Eluting Stents Landscape Analysis by Major Types

    • 10.2 Italy Drug-Eluting Stents Landscape Analysis by Major End-Users

    11. Spain Drug-Eluting Stents Landscape Analysis

    • 11.1 Spain Drug-Eluting Stents Landscape Analysis by Major Types

    • 11.2 Spain Drug-Eluting Stents Landscape Analysis by Major End-Users

    12. Poland Drug-Eluting Stents Landscape Analysis

    • 12.1 Poland Drug-Eluting Stents Landscape Analysis by Major Types

    • 12.2 Poland Drug-Eluting Stents Landscape Analysis by Major End-Users

    13. Russia Drug-Eluting Stents Landscape Analysis

    • 13.1 Russia Drug-Eluting Stents Landscape Analysis by Major Types

    • 13.2 Russia Drug-Eluting Stents Landscape Analysis by Major End-Users

    14. Switzerland Drug-Eluting Stents Landscape Analysis

    • 14.1 Switzerland Drug-Eluting Stents Landscape Analysis by Major Types

    • 14.2 Switzerland Drug-Eluting Stents Landscape Analysis by Major End-Users

    15. Turkey Drug-Eluting Stents Landscape Analysis

    • 15.1 Turkey Drug-Eluting Stents Landscape Analysis by Major Types

    • 15.2 Turkey Drug-Eluting Stents Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Landscape Analysis by Top Countries

      • 16.3.1 Denmark Drug-Eluting Stents Market Volume and Growth Rate

      • 16.3.2 Finland Drug-Eluting Stents Market Volume and Growth Rate

      • 16.3.3 Norway Drug-Eluting Stents Market Volume and Growth Rate

      • 16.3.4 Sweden Drug-Eluting Stents Market Volume and Growth Rate

      • 16.3.6 Iceland Drug-Eluting Stents Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Landscape Analysis by Top Countries

      • 17.3.1 Belgium Drug-Eluting Stents Market Volume and Growth Rate

      • 17.3.2 Netherlands Drug-Eluting Stents Market Volume and Growth Rate

      • 17.3.3 Luxembourg Drug-Eluting Stents Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Landscape Analysis by Top Countries

      • 18.3.1 Estonia Drug-Eluting Stents Market Volume and Growth Rate

      • 18.3.2 Latvia Drug-Eluting Stents Market Volume and Growth Rate

      • 18.3.3 Lithuania Drug-Eluting Stents Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Beijing AMSINO

      • 19.1.1 Beijing AMSINO Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Biosensors International

      • 19.2.1 Biosensors International Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Terumo

      • 19.3.1 Terumo Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Cook Medical

      • 19.4.1 Cook Medical Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Medtronic, Inc

      • 19.5.1 Medtronic, Inc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Biotronik

      • 19.6.1 Biotronik Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Shandong JW Medical

      • 19.7.1 Shandong JW Medical Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Abbott

      • 19.8.1 Abbott Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Liaoning Biomedical Materials R&D Center Co, Ltd (LBC)

      • 19.9.1 Liaoning Biomedical Materials R&D Center Co, Ltd (LBC) Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Balton

      • 19.10.1 Balton Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Boston Scientific.

      • 19.11.1 Boston Scientific. Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 AlviMedica Medical Technologies

      • 19.12.1 AlviMedica Medical Technologies Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

      • 19.13.1 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC) Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Lepu Medical

      • 19.14.1 Lepu Medical Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 MicroPort Scientific Corporation

      • 19.15.1 MicroPort Scientific Corporation Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 91 Figures and 124 Tables)

    • Figure Product Picture

    • Figure Europe Drug-Eluting Stents Market Size and Growth Rate of Rapamycin from 2014 to 2026

    • Figure Europe Drug-Eluting Stents Market Size and Growth Rate of Paclitaxel from 2014 to 2026

    • Figure Europe Drug-Eluting Stents Market Size and Growth Rate of Everolimus from 2014 to 2026

    • Figure Europe Drug-Eluting Stents Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Drug-Eluting Stents Market Size and Growth Rate of Angina Pectoris from 2014 to 2026

    • Figure Europe Drug-Eluting Stents Market Size and Growth Rate of Myocardial Infarction from 2014 to 2026

    • Figure Germany Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure UK Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure France Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Drug-Eluting Stents Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Drug-Eluting Stents Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Drug-Eluting Stents

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Drug-Eluting Stents by Different Types from 2014 to 2026

    • Table Consumption Share of Drug-Eluting Stents by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Rapamycin

    • Figure Market Size and Growth Rate of Paclitaxel

    • Figure Market Size and Growth Rate of Everolimus

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Drug-Eluting Stents by Different End-Users from 2014 to 2026

    • Table Consumption Share of Drug-Eluting Stents by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Angina Pectoris

    • Figure Market Size and Growth Rate of Myocardial Infarction

    • Table Europe Drug-Eluting Stents Production by Major Regions

    • Table Europe Drug-Eluting Stents Production Share by Major Regions

    • Figure Europe Drug-Eluting Stents Production Share by Major Countries and Regions in 2014

    • Table Europe Drug-Eluting Stents Consumption by Major Regions

    • Table Europe Drug-Eluting Stents Consumption Share by Major Regions

    • Table Germany Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table UK Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table France Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Italy Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Spain Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Poland Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Russia Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Switzerland Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Turkey Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Drug-Eluting Stents Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Drug-Eluting Stents Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Drug-Eluting Stents Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Drug-Eluting Stents Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Germany Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Germany Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Germany Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table UK Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table UK Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table UK Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table UK Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table France Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table France Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table France Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table France Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Italy Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Italy Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Italy Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Italy Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Spain Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Spain Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Spain Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Spain Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Poland Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Poland Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Poland Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Poland Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Russia Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Russia Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Russia Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Russia Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Switzerland Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Switzerland Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Switzerland Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Turkey Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Turkey Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Turkey Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug-Eluting Stents Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug-Eluting Stents Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug-Eluting Stents Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Drug-Eluting Stents Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Beijing AMSINO

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beijing AMSINO

    • Figure Sales and Growth Rate Analysis of Beijing AMSINO

    • Figure Revenue and Market Share Analysis of Beijing AMSINO

    • Table Product and Service Introduction of Beijing AMSINO

    • Table Company Profile and Development Status of Biosensors International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biosensors International

    • Figure Sales and Growth Rate Analysis of Biosensors International

    • Figure Revenue and Market Share Analysis of Biosensors International

    • Table Product and Service Introduction of Biosensors International

    • Table Company Profile and Development Status of Terumo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Terumo

    • Figure Sales and Growth Rate Analysis of Terumo

    • Figure Revenue and Market Share Analysis of Terumo

    • Table Product and Service Introduction of Terumo

    • Table Company Profile and Development Status of Cook Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cook Medical

    • Figure Sales and Growth Rate Analysis of Cook Medical

    • Figure Revenue and Market Share Analysis of Cook Medical

    • Table Product and Service Introduction of Cook Medical

    • Table Company Profile and Development Status of Medtronic, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic, Inc

    • Figure Sales and Growth Rate Analysis of Medtronic, Inc

    • Figure Revenue and Market Share Analysis of Medtronic, Inc

    • Table Product and Service Introduction of Medtronic, Inc

    • Table Company Profile and Development Status of Biotronik

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotronik

    • Figure Sales and Growth Rate Analysis of Biotronik

    • Figure Revenue and Market Share Analysis of Biotronik

    • Table Product and Service Introduction of Biotronik

    • Table Company Profile and Development Status of Shandong JW Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shandong JW Medical

    • Figure Sales and Growth Rate Analysis of Shandong JW Medical

    • Figure Revenue and Market Share Analysis of Shandong JW Medical

    • Table Product and Service Introduction of Shandong JW Medical

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Liaoning Biomedical Materials R&D Center Co, Ltd (LBC)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Liaoning Biomedical Materials R&D Center Co, Ltd (LBC)

    • Figure Sales and Growth Rate Analysis of Liaoning Biomedical Materials R&D Center Co, Ltd (LBC)

    • Figure Revenue and Market Share Analysis of Liaoning Biomedical Materials R&D Center Co, Ltd (LBC)

    • Table Product and Service Introduction of Liaoning Biomedical Materials R&D Center Co, Ltd (LBC)

    • Table Company Profile and Development Status of Balton

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Balton

    • Figure Sales and Growth Rate Analysis of Balton

    • Figure Revenue and Market Share Analysis of Balton

    • Table Product and Service Introduction of Balton

    • Table Company Profile and Development Status of Boston Scientific.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Scientific.

    • Figure Sales and Growth Rate Analysis of Boston Scientific.

    • Figure Revenue and Market Share Analysis of Boston Scientific.

    • Table Product and Service Introduction of Boston Scientific.

    • Table Company Profile and Development Status of AlviMedica Medical Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AlviMedica Medical Technologies

    • Figure Sales and Growth Rate Analysis of AlviMedica Medical Technologies

    • Figure Revenue and Market Share Analysis of AlviMedica Medical Technologies

    • Table Product and Service Introduction of AlviMedica Medical Technologies

    • Table Company Profile and Development Status of Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

    • Figure Sales and Growth Rate Analysis of Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

    • Figure Revenue and Market Share Analysis of Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

    • Table Product and Service Introduction of Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

    • Table Company Profile and Development Status of Lepu Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lepu Medical

    • Figure Sales and Growth Rate Analysis of Lepu Medical

    • Figure Revenue and Market Share Analysis of Lepu Medical

    • Table Product and Service Introduction of Lepu Medical

    • Table Company Profile and Development Status of MicroPort Scientific Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MicroPort Scientific Corporation

    • Figure Sales and Growth Rate Analysis of MicroPort Scientific Corporation

    • Figure Revenue and Market Share Analysis of MicroPort Scientific Corporation

    • Table Product and Service Introduction of MicroPort Scientific Corporation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US